Recruiting Heart Attack Studies in Frisco
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
In this clinical trial, participants with episodic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine d...
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
In this clinical trial, participants with chronic migraine will receive injections with Xeomin or Placebo into muscles of the head and neck. The purpose is to measure the change in monthly migraine da...
About Heart Attack Clinical Trials in Frisco
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Frisco, COLORADO. These studies are seeking a combined 1,770 participants. Research is being sponsored by Merz Therapeutics GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Frisco — FAQ
Are there heart attack clinical trials in Frisco?
Yes, there are 2 heart attack clinical trials currently recruiting in Frisco, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Frisco?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Frisco research site will contact you about next steps.
Are clinical trials in Frisco free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Frisco studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Frisco are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov